456070.KQ
Encell Co. Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 5,400.00
−3.74%Margins
Gross margin
-78.3%
EBITDA margin
-356.7%
EBIT margin
-352.3%
Net margin
-471.2%
FCF margin
-325.7%
-70.4%
Return on equity
-35.6%
Return on assets
-35.8%
Return on invested capital
0.07x
Asset turnover
-KRW 10.3B
Cash from operations
KRW 2.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026